Inovio Pharmaceuticals Inc (INO)

[KR_redondo]

IMVACS conference THURSDAY, August 15

Novel Vaccines: Innovations & Adjuvants


2:00 Skin Delivery of Flu Vaccine with Micro Arrays
Derek O'HaganDerek O'Hagan, Ph.D., Global Head, Vaccine Delivery Research, Novartis Vaccines

The coming years will see the introduction of a range of new vaccines against important infectious diseases. It will prove a challenge to incorporate these vaccines into the already crowded schedules for infant immunization. Moreover, many of these vaccines will be targeted at different population groups who may not normally accept regular vaccines, including adolescents and the elderly. It would be preferable for patient compliance if these vaccines could be administered without the use of conventional needles. Although novel rotes of vaccine delivery have been of long term interest, so far there has been limited commercial success. Nevertheless, progress has been made recently on skin delivery in particular. This presentation will review some of the technology concepts under current investigation, including skin delivery technologies.